![Professor Graham Scotland Professor Graham Scotland](/img/200x200/staffpages/uploads/heu020/Graham_Scotland_HERU.jpg)
Interim Director of HERU
- About
-
- Email Address
- g.scotland@abdn.ac.uk
- Telephone Number
- +44 (0)1224 437181
- School/Department
- School of Medicine, Medical Sciences and Nutrition
Biography
Graham is a Professor and leads the Assessment of Technologies theme in HERU. He joined HERU in 2004 and held a joint appointment between HERU and the Health Services Research Unit (HSRU) from 2012 to 2022. His current research interests span both model- and trial-based economic evaluation, with particular emphasis on the use decision analytic modelling alongside randomised controlled trials to maximise their value for informing health care decision making. Graham graduated from the University of Edinburgh in 1998 with BSc (Hons) in pharmacology, and following this undertook an MSc in Health Services and Public Health Research at the University of Aberdeen. After completing his MSc he worked at the Dugald Baird Centre for Research in Women's Health, University of Aberdeen, where he undertook research into economic aspects of maternal healthcare delivery in developing countries. Since his appointment in HERU he has gained over 19 years’ experience working in the area of health technology assessment. Graham also has an in interest in how the broader measures of value can incorporated in health technology assessment, and in 2012 completed a part-time PhD on methods for incorporating broader measures of value into economic evaluation in the area of reproductive healthcare.
- Publications
-
Page 3 of 9 Results 21 to 30 of 85
Palforzia for treating peanut allergy
London: Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence. 125 pagesBooks and Reports: Commissioned ReportsVenetoclax with a hypomethylating agent or low dose cytarabine for untreated acute myeloid leukaemia unsuitable for intensive chemotherapy
London: National Institute for Health and Care Excellence (NICE)Books and Reports: Commissioned ReportsBerotralstat for preventing acute attacks of hereditary angioedema
London: National Institute for Health and Care Excellence (NICE)Books and Reports: Commissioned ReportsCost-effectiveness and value of information analysis of multiple frequency bioimpedance devices for fluid management in people with chronic kidney disease having dialysis
Cost Effectiveness and Resource Allocation, vol. 19, 24Contributions to Journals: ArticlesThe Help for Hay Fever community pharmacy-based pilot randomised controlled trial for intermittent allergic rhinitis
npj Primary Care Respiratory Medicine, vol. 30, pp. 23Contributions to Journals: ArticlesGlyceryl trinitrate to reduce the need for manual removal of retained placenta following vaginal delivery: The GOT-IT RCT
Health Technology Assessment, vol. 23, no. 70, pp. 1-72Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.3310/hta23700
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/13665/1/Denison_GlycerylTrinitrateToReduce_VOR.pdf
- [ONLINE] View publication in Scopus
Atezolizumab monotherapy for untreated advanced non-small-cell lung cancer
Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care ExcellenceBooks and Reports: Commissioned ReportsDarolutamide with androgen deprivation therapy for treating non-metastatic hormone-relapsed prostate cancer
National Institute for Health and Care Excellence (NICE)Books and Reports: Commissioned ReportsEnzalutamide with ADT for treating metastatic hormone-sensitive prostate cancer
National Institute for Health and Care Excellence (NICE)Books and Reports: Commissioned ReportsNitroglycerin for treatment of retained placenta: A randomised, placebo-controlled, multicentre, double-blind trial in the UK
PLoS Medicine, vol. 16, no. 12, 1003001Contributions to Journals: Articles